Biotech - Press Releases

Date	Title	Company
26-Jul-2023	IO Biotech Announces Abstract Accepted for Mini Oral Presentation at IASLC 2023 World Conference on Lung Cancer	IO Biotech
26-Jul-2023	Quality Control Made Easy: CD Formulation's Microsphere Stability Testing	CD Formulation
25-Jul-2023	Biotech firm eyes rapid growth as relocation helps quadruple its operations	Recircle
25-Jul-2023	Golgi Neurosciences and Breye Therapeutics announce successful closing of P2X7 receptor antagonist program transfer	Golgi Neurosciences
25-Jul-2023	Nectero Medical Receives FDA Clearance of IND Application to Initiate Phase II/III Clinical Trial of Nectero EAST® System for Treatment of Small- to Mid-Sized Abdominal Aortic Aneurysms	Nectero Medical
25-Jul-2023	The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch	Molecure S.A.
25-Jul-2023	Polpharma Biologics Announces First-of-a-Kind Multiple Sclerosis Biosimilar Natalizumab Receives Positive CHMP Opinion	Polpharma Biologics
24-Jul-2023	Alfa Chemistry: 20 Best-Selling Graphene Products for Scientific Research Announced	Alfa Chemistry
22-Jul-2023	27th International Conference on Advanced Nanoscience and Nanotechnology	Allied Academies
21-Jul-2023	Toppan Holds VIRTUAL REMIX JAPAN™ Metaverse Event	Toppan
21-Jul-2023	Are shared medical appointments the key to solving global healthcare shortages?	ESMT Berlin
21-Jul-2023	Molecure completes successful Secondary Public Offering (SPO) of approximately PLN 50 million (USD 12 million) with proceeds to be used to fund and build a first in class, sustainable pipeline of breakthrough therapies	Molecure S.A.
21-Jul-2023	Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis	Tillotts Pharma
21-Jul-2023	Healthcare professionals react positively to RSV vaccine news, plus Crohn's disease, and heart failure drugs	bridgeheadcommunications.com
21-Jul-2023	The Science-Based Targets Initiative (SBTi) validates Almirall's 2030 emission reduction targets and its goal of achieving net zero emissions by 2050	Almirall
21-Jul-2023	Teva UK launches GoResp® Digihaler® (budesonide/ formoterol), the first integrated digital inhaler system for appropriate adult patients with asthma and COPD[i] in the UK	Teva UK Limited
21-Jul-2023	Researchers aim for rapid biomarker diagnostic test for stroke, using saliva	University of Birmingham
21-Jul-2023	HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study	HUTCHMED
21-Jul-2023	Healthcasts Introduces ConsensusAI, the First AI-Powered, Real-Time Patient Consultation Tool for Healthcare Professionals	Healthcasts
20-Jul-2023	Absolute Biotech Relaunches SCICONS™ dsRNA Antibodies and ELISA Kits	Absolute Biotech